EHSI Elite Health Systems Inc.
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1089815 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-348.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-155.6%
Net margin-261.7%
FCF margin—
EBITDA margin—
Returns
ROE-307.3%
ROA-247.2%
ROIC (approx.)-474.7%
Asset turnover0.94x
Leverage & solvency
Liabilities / assets34.4%
Debt / equity0.00x
Current ratio1.37x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.50x
Accruals ratio-122.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.02M | $0 | $0 | $0 | $1.06M |
| Cost of revenue | $906,000 | $0 | — | — | — |
| Gross profit | $118,000 | $0 | — | — | — |
| SG&A expense | $3.96M | $1.79M | $765,000 | $1.39M | $1.06M |
| Operating income | -$3.84M | -$1.79M | -$765,000 | -$1.39M | -$88,000 |
| Interest expense | — | — | $2,000 | $0 | $3,000 |
| Pretax income | -$7.80M | -$2.22M | -$816,000 | -$1.53M | -$553,000 |
| Income tax | $0 | -$163,000 | $0 | $39,000 | $420,000 |
| Net income | -$7.80M | -$2.06M | -$816,000 | -$1.34M | -$881,000 |
| EBITDA | -$3.83M | — | — | — | — |
| EPS (basic) | -0.35 | -0.13 | -0.09 | -0.09 | -0.11 |
| EPS (diluted) | — | — | -0.17 | -0.17 | -0.11 |
| Weighted avg. shares (diluted) | — | — | 9.28M | 7.84M | 7.79M |
| Balance sheet | |||||
| Cash & equivalents | $3.76M | $4.03M | $466,000 | $1.54M | $2.18M |
| Receivables | — | — | $0 | $0 | $0 |
| Current assets | $4.48M | $4.25M | $527,000 | $1.55M | $2.24M |
| PP&E, net | $7,000 | $72,000 | $85,000 | $20,000 | $59,000 |
| Goodwill | $984,000 | $0 | — | $0 | $315,000 |
| Total assets | $6.66M | $4.32M | $1.32M | $1.75M | $3.69M |
| Current liabilities | $1.34M | $94,000 | $607,000 | $280,000 | $626,000 |
| Total liabilities | $1.35M | $143,000 | $676,000 | $291,000 | $660,000 |
| Shareholders' equity | $5.31M | $4.18M | $645,000 | $1.24M | $2.58M |
| Shares outstanding | 28.52M | 19.98M | 9.28M | 7.79M | 7.79M |
| Cash flow statement | |||||
| Operating cash flow | -$2.94M | -$1.51M | -$891,000 | -$1.41M | $174,000 |
| Capital expenditure | $7,000 | $0 | — | — | — |
| Free cash flow | -$2.95M | -$1.51M | — | — | — |
| Investing cash flow | -$1.06M | $263,000 | -$180,000 | $772,000 | $63,000 |
| Financing cash flow | $3.73M | $4.82M | $0 | $0 | -$89,000 |
| Depreciation & amortization | $6,000 | — | — | — | — |
| Stock-based compensation | $569,000 | $0 | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.